Pfizer’s first quarter results drew a positive market response as management emphasized margin improvement and disciplined ...

Pharma companies met with the Trump administration earlier this month to try and defer implementation of the executive order ...

Pfizer’s 7%+ yield is tempting, but rising political, regulatory, and business risks threaten its stability and growth ...

The Health Secretary's attended the Bilderberg Meeting in Sweden, sipping champagne in the company of billionaires, bankers ...

PwC analysts have warned the speedy evolution of the Chinese biotech sector is creating “heightened risks related to IP ...

Pfizer Inc. (NYSE:PFE) is one of the 15 best stocks to invest in for an 18 year old. On June 10, Cantor Fitzgerald reaffirmed ...

Pfizer has promoted Albert Bourla, seen as a likely successor to incumbent CEO Ian Read, to the newly-created role of chief operating officer. The move could help Read focus on long-term strategy ...

Pfizer’s CEO Ian Read is to step down after eight years and will be replaced on 1st January by chief operating officer Albert Bourla. In contrast to Merck & Co. which has rescinded a company ...

Pfizer is undervalued as markets fixate on its patent cliff, overlooking strong cash flows, pipeline upside, and a 7% yield.

Fi launched the world's first AI-powered dog collar tracking scratching, licking, sleep cycles and location to provide pet parents insights about their dog's well-being. Dave Portnoy weighs in on ...

Rob Lynch shares the fast-food chain’s growth strategies, including supply chain improvements, menu innovation and international expansion. He also discusses founder Danny Meyer’s support in advancing ...